# AISAP

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aisap

- Industry: Software
- Headquarters: Tel Aviv, Israel
- Website: www.aisap.ai/
- Total disclosed funding: $13M
- Latest round: Seed (May 2, 2024)
- Investors on record: 2

## About

Based in Tel Aviv, Israel, and founded in 2022, AISAP Ltd. operates as an AI solution for real-time diagnosis, interpretation, storage, and reporting of ultrasound studies at the point of care. Adiel Am-Shalom (CTO), Ehud Raanani, Ehud Schwammenthal, and Robert Klempfner (CMO) are the co-founders of the company. In May 2024, AISAP Ltd. raised USD 13 million in seed funding led by Harel Insurance Investments & Financial Services Ltd. and Shoni Health Ventures. As of 2024, the company is led by its CEO, Roni Attali.

The company develops POCAD (Point of Care Assisted Diagnosis), which focuses on medical diagnostics with its SAAS platform that utilizes AI-powered ultrasound technology to provide accurate diagnoses. POCAD's offering is its interface, which guides healthcare professionals through the entire diagnostic process, from scan to report. The firm’s real-time scanning assistance ensures optimal image acquisition, while AI-driven analytics provide insights to operators. The company's key strength is its integration with any point-of-care ultrasound device (POCUS) and electronic health systems. 

POCAD's plug-and-play installation and AI components make it accessible for users of all skill levels, from primary care clinics to hospital emergency departments. The platform's advanced features include digitally guided acquisition assistance, AI-based diagnosis, reviewing systems, and structured POCUS reports. In addition, the firm offers online training resources to support continuous learning and skill development.

## Funding rounds

- Seed, May 2, 2024, $13M — Harel Insurance Investments, Shoni Health Ventures

## Investors

- Harel Insurance Investments — Seed
- Shoni Health Ventures (https://capitalatlas.ai/funds/shoni-health-ventures) — Seed